DNA
$1.82
Revenue | $80.57Mn |
Net Profits | $-173.32Mn |
Net Profit Margins | -215.12% |
Ginkgo Bioworks Holdings Inc’s revenue fell -44.29% since last year same period to $80.57Mn in the Q2 2023. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -0.17% fall in its revenue since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit jumped 74.09% since last year same period to $-173.32Mn in the Q2 2023. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 15.44% jump in its net profits since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit margin jumped 53.49% since last year same period to -215.12% in the Q2 2023. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 15.3% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Current Year | -0.09 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.09 - a 28.5% jump from last quarter’s estimates.
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.09.
Earning Per Share (EPS) | 0 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Ginkgo Bioworks Holdings Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-09 | -0.09 | 0 | 100% |
2023-05-10 | -0.12 | 0 | 100% |